Connor, Clark & Lunn Investment Management (CC&L)’s Myriad Genetics MYGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.37M | Buy |
1,387,832
+465,921
| +51% | +$2.47M | 0.03% | 479 |
|
|
2025
Q1 | $8.18M | Buy |
921,911
+372,455
| +68% | +$3.3M | 0.04% | 370 |
|
|
2024
Q4 | $7.53M | Buy |
549,456
+434,420
| +378% | +$5.96M | 0.03% | 384 |
|
|
2024
Q3 | $3.15M | Buy |
115,036
+93,171
| +426% | +$2.55M | 0.02% | 554 |
|
|
2024
Q2 | $535K | Buy |
+21,865
| New | +$535K | ﹤0.01% | 1035 |
|
|
2024
Q1 | – | Sell |
-61,357
| Closed | -$1.17M | – | 1656 |
|
|
2023
Q4 | $1.17M | Sell |
61,357
-74,917
| -55% | -$1.43M | 0.01% | 817 |
|
|
2023
Q3 | $2.19M | Buy |
136,274
+16,589
| +14% | +$266K | 0.01% | 597 |
|
|
2023
Q2 | $2.77M | Buy |
119,685
+59,242
| +98% | +$1.37M | 0.01% | 523 |
|
|
2023
Q1 | $1.4M | Buy |
60,443
+49,408
| +448% | +$1.15M | 0.01% | 636 |
|
|
2022
Q4 | $160K | Buy |
+11,035
| New | +$160K | ﹤0.01% | 1079 |
|
|
2021
Q1 | – | Sell |
-44,442
| Closed | -$879K | – | 1053 |
|
|
2020
Q4 | $879K | Sell |
44,442
-40,022
| -47% | -$792K | 0.01% | 655 |
|
|
2020
Q3 | $1.1M | Buy |
+84,464
| New | +$1.1M | 0.01% | 603 |
|
|
2019
Q1 | – | Sell |
-27,466
| Closed | -$798K | – | 1003 |
|
|
2018
Q4 | $798K | Sell |
27,466
-36,225
| -57% | -$1.05M | 0.01% | 596 |
|
|
2018
Q3 | $2.93M | Buy |
63,691
+19,766
| +45% | +$909K | 0.02% | 381 |
|
|
2018
Q2 | $1.64M | Buy |
43,925
+28,575
| +186% | +$1.07M | 0.01% | 521 |
|
|
2018
Q1 | $454K | Buy |
+15,350
| New | +$454K | ﹤0.01% | 584 |
|
|
2014
Q2 | – | Sell |
-40,100
| Closed | -$1.51M | – | 602 |
|
|
2014
Q1 | $1.51M | Sell |
40,100
-66,100
| -62% | -$2.49M | 0.01% | 312 |
|
|
2013
Q4 | $2.37M | Buy |
106,200
+43,300
| +69% | +$965K | 0.02% | 240 |
|
|
2013
Q3 | $1.52M | Buy |
62,900
+34,500
| +121% | +$833K | 0.01% | 224 |
|
|
2013
Q2 | $805K | Buy |
+28,400
| New | +$805K | 0.01% | 290 |
|